Product Information
IRBESARTAN 75 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0823 per EA under NDC 43547037409. Its NADAC has been published 515 times since Nov 23, 2016.
FDA first approved this application on Sep 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547037409
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203071FDA Approved
9/27/2012
TE Code
AB
On Market Since
6/13/2016
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 75 MG TABLET has been published 515 times since Nov 23, 2016, and over the history we have for it it has declined 57.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0823 per EA |
|---|---|
| All-time high | $0.3279 (Jan 15, 2020) |
| All-time low | $0.0800 (May 20, 2026) |
| 52-week high | $0.1039 |
| 52-week low | $0.0800 |
| Median price | $0.1613 |
| Average price | $0.1639 |
| Largest weekly change | +39.1% (Dec 18, 2019) |
| Weeks tracked | 515 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Irbesartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IRBESARTAN 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 75 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0823 per EA (NDC 43547037409), effective Sep 30, 2026.
How has the price of IRBESARTAN 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 75 MG TABLET has declined 57.2%. It has been tracked across 515 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 75 MG TABLET?
Since Nov 23, 2016, the NADAC for IRBESARTAN 75 MG TABLET has ranged from a low of $0.0800 (May 20, 2026) to a high of $0.3279 (Jan 15, 2020), with a median of $0.1613 per EA.
Are there cheaper alternatives to IRBESARTAN 75 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IRBESARTAN 75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IRBESARTAN 75 MG TABLET?
IRBESARTAN 75 MG TABLET (NDC 43547037409) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.